In case you missed it, our CEO, Jerry McLaughlin, attended the 11th Aging Research & Drug Discovery Meeting 2024 in Copenhagen! He shared an update on our #EpigeneticReprogramming platform and participated in a panel for biotechs specializing in #AgeRelatedDiseases. Thank you, ARDD, for the chance to connect with other experts and learn more about recent advancements in the field.
Exciting
Love this.
Exciting
VIP Flight Attendant
1mo🙌🏻